Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

• Status: Completed
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a local, prospective, multicenter, non-interventional, observational study. Primary objective is to describe how in "real life" thromboprophylaxis is carried out after the discharge from a hospital in the patients who undergo elective knee and hip replacement and who receive Xarelto during hospitalization.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Collaborator: Janssen Research & Development, LLC
• Treatments: Rivaroxaban

Criteria

Inclusion Criteria:

• Male and female patients ≥ 18 years old

• Elective hip or knee replacement

• Planned VTE prevention with Xarelto

• Written informed consent

• The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.

Exclusion Criteria:

• Contraindications for the use of Xarelto in accordance with the effective instruction

• Any reasons of medical and non-medical character, which in the opinion of the physician can hamper participation of the patient in NIS, including a potentially low compliance, impossibility of making the final visit due to distant place of residence of the patient.